Immune deviation following stress odor exposure: Role of endogenous opioids

Journal of Neuroimmunology

Volumn 102, Issue 2, 2000, Pages 145-153

  Moynihan, Jan A ^a   Karp, Jonathan D ^b   Cohen, Nicholas ^a   Ader, Robert ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b RIDER UNIVERSITY   (United States)

Author keywords

Antibody; Mice; Opioids; Psychosocial stress; Th2 cytokines

Indexed keywords

DRINKING WATER; ENDORPHIN; INTERLEUKIN 4; NALTREXONE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; IMMUNE RESPONSE; MALE; MENTAL STRESS; MOUSE; NEUROIMMUNOLOGY; NONHUMAN; ODOR; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

ADMINISTRATION, ORAL; ANALGESIA; ANIMALS; ANTIBODY FORMATION; CELLS, CULTURED; ENDORPHINS; HEMOCYANIN; IMMUNE SYSTEM; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN-4; MALE; MICE; MICE, INBRED BALB C; NALTREXONE; NARCOTIC ANTAGONISTS; ODORS; SPLEEN; STRESS, PSYCHOLOGICAL;

EID: 0033992444     PISSN: 01655728     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0165-5728(99)00173-3     Document Type: Article

References (60)

1. Brenner G.J., Cohen N., Moynihan J.A. Similar immune responses to subcutaneous footpad infection with herpes simplex virus-1 in sensitive (BALB/c) and resistant (C57Bl/6) strains of mice. Cell. Immunol. 157:1994;510-524.
2. Bretscher P.A., Wei G., Menjon J.N., Bielefeldt-Ohmann H. Establishment of stable, cell-mediated immunity that makes 'susceptible' mice resistant to Leishmania major. Science. 257:1994;539-542.
3. Carpenter G.W., Carr D.J.J. Pretreatment with β-funaltrexamine blocks morphine-mediated suppression of CTL activity in alloimmunized mice. Immunopharmacology. 29:1995;129-140.
4. Carr D.J.J., France C.P. Immune alterations in morphine-treated Rhesus monkeys. J. Pharmacol. Exp. Ther. 267:1993;9-15.
5. Carr D.J.J., Rogers T.J., Weber R.J. The relevance of opioids and opioid receptors on immunocompetence and immune homeostasis. Proc. Soc. Exp. Biol. Med. 213:1996;248-257.
6. Cocke R., Moynihan J.A., Cohen N., Grota L.J., Ader R. Exposure to conspecific alarm chemosignals alters immune responses in BALB/c mice. Brain Behav. Immun. 7:1993;36-46.
7. Cohen, S., 1994. Psychosocial influences on immunity and infectious disease in humans. In: Glaser, R., Kiecolt-Glaser, J.K. (Eds.), Handbook of Human Stress and Immunity. Academic Press, New York, pp. 301-319.
8. Decker D., Schondorf M., Bidlingmaier F., Hirner A., vonRuecker A.A. Surgical stress induces a shift in the type-1/type-2 T-helper cell balance, suggesting down-regulation of cell-mediated and up-regulation of antibody-mediated immunity commensurate to the trauma. Surgery. 119:1996;316-325.
9. Dobbs C.M., Feng N., Beck M., Sheridan J.F. Neuroendocrine regulation of cytokine production during experimental influenza viral infection: effects of restraint stress-induced elevation in endogenous corticosterone. J. Immunol. 157:1996;1870-1877.
10. Eisenstein T.K., Hilburger M.E. Opioid modulation of immune responses: effects on phagocyte and lymphocyte populations. J. Neuroimmunol. 83:1998;36-44.
11. Elenkov I.J., Papanicolaou D.A., Wilder R.L., Chrousos C.P. Modulatory effects of glucocorticoids and catecholamines on human interleukin-12 and interleukin-10 production: clinical implications. Proc. Assoc. Am. Physicians. 108:1996;374-381.
12. Fawzy, F.I., Fawzy, N.W., 1994. Psychoeducational interventions and health outcomes. In: Glaser, R., Kiecolt-Glaser, J.K. (Eds.), Handbook of Human Stress and Immunity. Academic Press, New York, pp. 365-402.
13. Fecho K., Dykstra L.A., Lysle D.T. Evidence for beta adrenergic receptor involvement in the immunomodulatory effects of morphine. J. Pharmacol. Exp. Ther. 265:1993;1079-1087.
14. Fecho K., Maslonek K.M., Dykstra L.A., Lysle D.T. Assessment of the involvement of central nervous system and peripheral nervous system opioid receptors in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 276:1996;626-636.
15. Fecho K., Maslonek K.A., Dykstra L.A., Lysle D.T. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J. Pharmacol. Exp. Ther. 277:1996;633-645.
16. Freier D.O., Fuchs B.A. A mechanism of action for morphine-induced immunosuppression: corticosterone mediates morphine-induced suppression of natural killer cell activity. J. Pharmacol. Exp. Ther. 271:1994;1127-1133.
17. Fuchs B.A., Pruett S.B. Morphine induced apoptosis in murine thymocytes in vivo but not in vitro: involvement of both opiate and glucocorticoid receptors. J. Pharmacol. Exp. Ther. 266:1993;417-423.
18. Golding B., Zaitseva M., Golding H. The potential for recruiting immune responses toward type 1 or type 2 T cell help. Am. J. Trop. Med. Hyg. 50:1994;33-40. Supplement.
19. Guery J.-C., Galbiati F., Smiroldo S., Adorini L. Selective development of T helper (Th)2 cells induced by continuous administration of low dose soluble proteins to normal and β2-microglobulin-deficient BALB/c mice. J. Exp. Med. 183:1996;485-497.
20. Harris L.S., Pierson A.K. Some narcotic antagonists in the benzomorphan series. J. Pharmacol. Exp. Ther. 143:1964;141-148.
21. Heinzel F.P., Sadick M.D., Holaday B.J., Coffman R.L., Locksley R.M. Reciprocal expression of interferon-g or interleukin-4 during the resolution of murine Leishmaniasis. J. Exp. Med. 169:1989;59-72.
22. Hernandez M., Flores L.R., Bayer B.M. Immunosuppression by morphine is mediated by central pathways. J. Pharmacol. Exp. Ther. 267:1993;1336-1341.
23. Horan P., Taylor J., Yamamura H.I., Porreca F. Extremely long-lasting antagonistic actions of nor-binaltorphamine (nor-BNI) in the mouse tail-flick test. J. Pharmacol. Exp. Ther. 260:1992;1237-1243.
24. Hosken N.A., Shibuya K., Heath A.W., Murphy K.M., O'Garra A. The effect of antigen dose on CD4+ T helper cell phenotype development in a T cell receptor-αβ-transgenic model. J. Exp. Med. 182:1995;1579-1584.
25. Hsueh C., Chen S., Huang H., Ghanta V.K., Hiramoto R.N. Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity. Brain Res. 737:1996;263-268.
26. Kiecolt, J.K., Glaser, R., 1991. Stress and immune function. In: Ader, R., Felten, D.L., Cohen, N. (Eds.), Psychoneuroimmunology. Academic Press, New York, pp. 849-868.
27. Kiecolt-Glaser, J.K., Malarkey, W.B., Cacioppo, J.T., Glaser, R., 1994. Stressful personal relationships: immune and endocrine function. In: Glaser, R., Kiecolt-Glaser, J.K. (Eds.), Handbook of Human Stress and Immunity. Academic Press, New York, pp. 321-339.
28. Levy S.M., Herberman R.B., Lee J., Whiteside T., Sanzo K., Kirkwood J. Perceived social support and tumor estrogen/progesterone receptor status as predictors of natural killer cell activity in breast cancer patients. Psychosom. Med. 52:1990;73-85.
29. Lichtman A.H., Fanselow M.S. Cats produce analgesia in rats on the tail-flick test: naltrexone sensitivity is determined by the nociceptive test stimulus. Brain Res. 533:1990;91-94.
30. Lockwood L.L., Silbert L.H., Fleshner M., McNeal C., Watkins L.R., Laudenslager M.L., Rice K.C., Weber R.J., Maier S.F. Morphine-induced alterations in antibody levels: receptor and immune mechanisms. J. Pharmacol. Exp. Ther. 278:1996;689-696.
31. Lysle D.T., Coussons M.E., Watts V.J., Bennett E.H., Dykstra L.A. Morphine-induced alterations of immune status: dose dependency, compartment specificity, and antagonism by naltrexone. J. Pharmacol. Exp. Ther. 265:1993;1071-1078.
32. Madden J.J., Whaley W.L., Ketelsen D. Opiate binding sites in the cellular immune system: expression and regulation. J. Neuroimmunol. 83:1998;57-62.
33. Maes M., Song C., Lin A., De Jongh R., Van Gastel A., Kenis G., Bosmans E.D., Benoy I., Neels H., Demedts P., Janca A., Scharpe S., Smith R.S. The effects of psychological stress on humans: increased production of pro-inflammatory cytokines and a Th1-like response in stress-induced anxiety. Cytokine. 10:1998;313-318.
34. Maity R., Mukherjee R., Skolnick P. Morphine inhibits the development of allogeneic immune responses in mouse lymph nodes. Immunopharmacology. 29:1995;175-183.
35. Matthes T. Experimental contribution to the question of emotional stress reactions to tumor growth. Proc. 8th Anti-Cancer Cong. 3:1963;1608-1610.
36. Mellon R.D., Bayer B.M. Role of central opioid receptor subtypes in morphine-induced alterations in peripheral lymphocyte activity. Brain Res. 789:1998;56-67.
37. Moynihan J.A., Karp J.D., Cohen N., Cocke R. Alterations in interleukin-4 and antibody production following pheromone exposure: role of glucocorticoids. J. Neuroimmunol. 54:1994;51-58.
38. O'Garra A., Murphy K. Role of cytokines in development of Th1 and Th2 cells. Chem. Immunol. 63:1996;1-13.
39. Panerai A.E., Sacerdote P. β-Endorphin in the immune system: a role at last. Immunol. Today. 18:1997;317-319.
40. Panerai A.E., Radulovic J., Monastra G., Manfredi B., Locatelli L., Sacerdote P. Beta-endorphin concentrations in brain areas and peritoneal macrophages in rats susceptible and resistant to experimental allergic encephalomyelitis: a possible relationship between tumor necrosis factor alpha and opioids in the disease. J. Neuroimmunol. 51:1994;169-176.
41. Panerai A.E., Manfredi B., Granucci F., Sacerdote P. The beta-endorphin inhibition of mitogen-induced splenocytes proliferation is mediated by central and peripheral paracrine/autocrine effects of the opioid. J. Neuroimmunol. 58:1995;71-76.
42. Paul W.E., Seder R.A. Lymphocyte responses and cytokines. Cell. 76:1994;241-251.
43. Pawelec G., Rehbein A., Schlotz E., Friccius H., Pohla H. Cytokine modulation of TH1/TH2 phenotype differentiation in directly alloresponsive CD4+ human T cells. Transplantation. 62:1996;1095-1101.
44. Payne D.K., Sullivan M.D., Massie M.J. Women's psychological reactions to breast cancer. Semin. Oncol. 23(S2):1996;89-97.
45. Peterson P.K., Molitor T.W., Chao C.C. The opioid-cytokine connection. J. Neuroimmunol. 83:1998;63-69.
46. Rogers M.P., Trentham E., McCune J., Ginsburg B., Rennke H., Reich P., David J. Effects of psychosocial stress on the induction of arthritis in the rat. Arthritis Rheum. 23:1980;1337-1342.
47. Romagnani S. Th1 and Th2 in human diseases. Clin. Immunol. Immunopathol. 80:1996;225-235.
48. Romagnani S. The Th1/Th2 paradigm. Immunol. Today. 18:1997;263-266.
49. Sadick M.D., Heinzel F.P., Holaday B.J., Pu R.T., Dawkins R.S., Locksley R.M. Cure of murine leishmaniasis with anti-interleukin-4 monoclonal antibody. J. Exp. Med. 171:1990;115-127.
50. Sharp B.M., Roy S., Bidlack J.M. Evidence for opioid receptors on cells involved in host defense and the immune system. J. Neuroimmunol. 83:1998;45-56.
51. Shavit, Y., 1991. Stress-induced immunomodulation in animals: opiates and endogenous opioid peptides. In: Ader, R., Felten, D.L., Cohen, N. (Eds.), Psychoneuroimmunology. Academic Press, New York, pp. 789-806.
52. Sheridan J.F., Dobbs C., Brown D., Zwilling B. Psychoneuroimmunology: stress effects on pathogenesis and immunity during infection. Clin. Microbiol. Rev. 7:1994;200-212.
53. Shibata H., Fijiwara R., Iwamoto M., Matsuoka H., Yokoyama M.M. Recovery of PFC in mice exposed to high pressure stress by olfactory stimulation with fragrance. Int. J. Neurosci. 51:1990;245-247.
54. Spiegel, D., Kraemer, H., Bloom, J., Gottheil, E., 1989. Effect of psychosocial treatment on survival of patients with metastatic breast cancer. The Lancet, October, 888-891.
55. Stefano G.B., Scharrer B., Smith E.M., Hughes T.K., Magazine H.I., Bilfinger T.V., Hartman A.R., Fricchione G.L., Liu Y., Makman M.H. Opioid and opiate regulatory processes. Crit. Rev. Immunol. 16:1996;109-144.
56. Sutton L.C., Fleshner M., Mazzeo R., Maier S.F., Watkins L.R. A permissive role of corticosterone in an opioid form of stress-induced analgesia: blockade of opiate analgesia is not due to stress-induced hormone release. Brain Res. 663:1994;19-29.
57. Weigent, D.A., Blalock, J.E., 1994. In: Scharrer, B., Smith, E.M., Stefanol, G.B. (Eds.), Role of Neuropeptides in the Bidirectional Communication Between the Immune and Neuroendocrine Systems. Springer-Verlag, New York, pp. 14-27.
58. Wiedermann C.J., Sacerdote P., Propst T., Judmaier G., Kathrein H., Vogel W., Panerai A.E. Decreased beta-endorphin content in peripheral blood mononuclear leukocytes from patients with Crohn's disease. Brain Behav. Immun. 8:1994;261-269.
59. Yeager M.P., Colacchio T.A., Yu C.T., Hildebrandt L., Howell A.L., Weiss J., Guyre P.M. Morphine inhibits spontaneous and cytokine-enhanced natural killer cell cytotoxicity in volunteers. Anesthesiology. 83:1995;500-508.
60. Zalcman S., Kerr L., Anisman H. Immunosuppression elicited by stressors and stress-related odors. Brain Behav. Immun. 5:1991;262-274.